CLG mining electronic medical record data gold (1)

High-tech hospitals are currently are using electronic medical record system management clinical research, to improve the quality of medical services, as well as the implementation of business decisions.

Clinical research usually takes several years.

A simple example: a gatifloxacin (gatifloxacin) clinical study showed that the widespread use of antibiotics can cause blood glucose fluctuations for diabetic patients at risk. But after further research has shown that the risk of side effects of drugs on the health of all patients are causing a serious threat, as a result, the sector will be pulled out of the pharmaceutical market.

Bronx in New York City in Monte Fiore Medical Center, an analyst for gatifloxacin clinical study of this tremendous interest, and use the new clinical data analysis tools on the results of this study.

The analysts are selected the four hospitals in the patients of the two groups, a group taking gatifloxacin, a group of taking another antibiotic, and the comparison of the two groups. There is no doubt that the results of the comparison to take gatifloxacin group of patients with high blood sugar may appear or the risk of high blood glucose complications in another set of six times.

Unlike traditional methods, the analysts do not have to be on this drug for several months or even years of research: neither visit physicians Committee or data experts to do research, not waiting for the soon to be published in academic journals on the results of the study.

He only need lunch a gap, use a lens called "clinical" (Clinical Looking Glass, hereinafter referred to as the CLG) software, the software contains more than ten years of medical electronic medical record data.

This software for the whole patient samples of data cannot be confirmed (de-identified data) are explained, in order to measure the effectiveness of measures for patient safety, to identify and track public health threats and for professional articles and research papers published with data sources.

CLG has been used for the following areas: measuring health rules on the rehabilitation of patients, to reduce the amount of radiation exposure in the emergency department patients of quantitative analysis, and long-term care in diabetes care and treatment monitoring progress tracking.

Moreover, in times of heparin panic, CLG also help medical institutions on FDA carried out emergency clinical hospital-wide system of making rapid response, to determine the patients taking anticoagulant drugs can cause a longer period of hospitalization and higher mortality rates.

Monte Fiore's analysts quickly followed from December 2007 to January 2008, all have taken during anticoagulant patient data, and in-hospital mortality of two cycles and levels, and associate it with 1 years ago did not raise the issue of quality over the use of the drug were compared to the patients. The result is not found there are significant differences, so there is no reason to make the Monte Fiore of anticoagulant drugs in patients with vigilant.

"Do these analyses in order to collect clinical data and guide the conduct of clinical studies, ultimately helping doctors make better clinical decision making," Monte Montefiore Medical Center, Deputy Director of clinical information technology departments, and also the CLG's design consultant Dr. Eran Bellin told reporters, "use the CLG query, quantitative evidence has already been applied to many published in core-level academic journals papers, professional meeting report, a number of medical institutions within the scope of the improvement of the quality of patient care and benefit the people of proposal on health of major projects, and so on.

”

Monte Montefiore Medical Center Director and CEO, said Dr Steven Safyer, the emergence of "CLG let us understand that medical information on the future of health impact is immeasurable.

”

Medical data in the big bang

Under the impetus of the Government, and widely used electronic medical records, regardless of whether clinical significance or commercial purposes on the use of the data for the second hand will be rendered explosive growth.

From New York City law firm partner, PWC and health information technology project Manager Dan Garrett commented, "this change will have on health economics and far-reaching influence. ”

"Once we began using independent value-added way clinical, financial and management data, will bring enormous benefits to the valuation of growth.

”

"The most far-reaching influence comes from the clinical, financial and management data to give some simple examples, such as treatment options, results, GPO (drugs purchased model contract information), ICD9 coding with ICD10 disease, diagnosis and treatment of patients and clinicians time, patients account records and medical equipment cost and so on.

When the relevant bodies of the acquisition, processing and analysis of these data, it will give us a vivid image and tell us what useful and what is useless. ”